Literature DB >> 2952595

Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus.

D G Heath, P P Cleary.   

Abstract

DNA containing the 5' end of the M-12 structural gene was used as a probe in colony hybridizations in an attempt to clone the M-76 gene from an M-type 76 group A streptococcal strain. A single positive colony was detected, and Southern hybridization analysis of plasmid DNA isolated from this colony indicated that the insert DNA had homology to the 5' end of the M-12 structural gene. Subclones were constructed to define the limits of the M-76 gene, and sonicates of these subclones were reacted with M-76-specific antiserum in immunodiffusion. A sonicate of one subclone, JM83(pDH56), reacted strongly with the M-76-specific antiserum but also reacted with preimmune rabbit serum. Protein expressed from this subclone bound immunoglobulin from horse and pig, as well as human myeloma immunoglobulin G (IgG) representing all four subclasses and purified human IgG Fc fragments. This indicated that JM83(pDH56) expressed a protein with characteristics previously attributed to the IgG Fc receptor protein from group A streptococci. Western blot analysis indicated that the cloned IgG Fc receptor protein had a molecular weight of approximately 29,000. Binding studies showed that the Fc receptor gene is expressed by the M-type 76 strain from which it was cloned and by an M- variant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952595      PMCID: PMC260495          DOI: 10.1128/iai.55.5.1233-1238.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Demonstration of the non-identity between the Fc receptor for human IgG from group A streptococci type 15 and M protein, peptidoglycan and the group specific carbohydrate.

Authors:  P Christensen; A Grubb; R Grubb; G Samuelsson; C Schalén; M L Svensson
Journal:  Acta Pathol Microbiol Scand C       Date:  1979-06

Review 3.  M proteins of group A streptococci.

Authors:  E N Fox
Journal:  Bacteriol Rev       Date:  1974-03

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Small DNA deletions creating avirulence in Streptococcus pyogenes.

Authors:  J G Spanier; S J Jones; P Cleary
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

6.  Colony hybridization.

Authors:  M Grunstein; J Wallis
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

7.  Identification of distinct Fc-receptor molecules on streptococci and staphylococci.

Authors:  K J Reis; M D Boyle; E M Ayoub
Journal:  J Clin Lab Immunol       Date:  1984-02

8.  Electron microscopic study of the location of the Fc-reacting factor on group A streptococci.

Authors:  M Rýc; M Wagner; B Wagner; J Havlicek
Journal:  Microbios       Date:  1982

9.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

10.  Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein.

Authors:  V A Fischetti; K F Jones; B N Manjula; J R Scott
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  16 in total

1.  Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci.

Authors:  R Raeder; R A Otten; L Chamberlin; M D Boyle
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49.

Authors:  E J Haanes; P P Cleary
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

3.  Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci.

Authors:  G Lindahl; L Stenberg
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

4.  Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains.

Authors:  C E Yu; J J Ferretti
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

5.  M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin.

Authors:  D S Retnoningrum; P P Cleary
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate.

Authors:  M D Boyle; J Hawlitzky; R Raeder; A Podbielski
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

7.  Cell surface proteins of a group A streptococcus type M4: the IgA receptor and a receptor related to M proteins are coded for by closely linked genes.

Authors:  G Lindahl
Journal:  Mol Gen Genet       Date:  1989-04

8.  Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class.

Authors:  E J Haanes; D G Heath; P P Cleary
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

9.  Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli.

Authors:  H Janson; L O Hedén; A Grubb; M R Ruan; A Forsgren
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.

Authors:  Y Ji; L McLandsborough; A Kondagunta; P P Cleary
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.